Details of the Drug

General Information of Drug (ID: DMQ47U6)

Drug Name
CR8020
Synonyms H3N2 and H7N7 influenza monoclonal antibody therapy, Crucell
Indication
Disease Entry ICD 11 Status REF
Influenza virus infection 1E30-1E32 Phase 2 [1]
Influenza A virus infection 1E30 Investigative [2]
Drug Type
Antibody
Cross-matching ID
TTD ID
D0B1IC

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Influenza Hemagglutinin (Influ HA) TTF4CAM HEMA_I34A1 Not Available [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT01992276) Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
3 Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin. J Virol. 2014 Dec;88(23):13580-92.